NCT06690307View on ClinicalTrials.gov

Oxycodone Versus Sufentanil in Patient-controlled Intravenous Analgesia After Laparoscopic Hysterectomy

PHASE4RecruitingINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

December 3, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

July 31, 2026

Conditions
Laparoscopic Hysterectomy
Interventions
PROCEDURE

patient controlled intravenous analgesia(PCIA)

Patients will receive sulfentanil for PCIA.

PROCEDURE

patient controlled intravenous analgesia(PCIA)

Patients will receive oxycodone for PCIA.

Trial Locations (1)

226001

RECRUITING

Affiliated hospital of Nantong University, Nantong

All Listed Sponsors
lead

Affiliated Hospital of Nantong University

OTHER

NCT06690307 - Oxycodone Versus Sufentanil in Patient-controlled Intravenous Analgesia After Laparoscopic Hysterectomy | Biotech Hunter | Biotech Hunter